IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
Dave Li
Advertisement
Articles by Dave Li
Dave Li explores the current information on the commercialization of advanced therapy medicinal products.
Advertisement
Latest Updated Articles
European Regulatory Framework and General Path to Market for ATMPsPublished: September 17th 2019 | Updated:
Initial Design Considerations of Trials of Immuno-Oncology: Domains and ElementsPublished: June 4th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Broader Investigator Networks to Advance Global Breast Cancer Research
2
AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions
3
dashClinical: Real-Time Participant Payments
4
ACT Brief: AI Partnerships, Global Trial Access, and a New Option for Menopause Symptoms
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
